Mark Freeman, MD
Adult Reconstructive Orthopaedic Surgery · Chattanooga, TNNPI 1780667865
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 78.1% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2019 at $48,737 and has fallen 98.6% since, to $663 in 2025.
Across 135 payments — averaging $620.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$65K
- Conformis, Inc.$10K
- Steris Corporation$7K
- Orthalign Inc$175
- Smoky Mountain Surgical LLC$164
- Johnson & Johnson$160
- plus $1K from 29 others
Across 34 payments — averaging $3735.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$127K
What the payments were for
- Consulting fees$19,65523%
- Speaking & faculty fees$49,22559%
- Travel & lodging$10,61013%
- Food & beverage$4,3405%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 65 | $65,496 |
| Conformis, Inc. | 10 | $9,775 |
| Steris Corporation | 2 | $6,572 |
| Orthalign Inc | 1 | $175 |
| Smoky Mountain Surgical LLC | 4 | $164 |
| Johnson & Johnson(2 entities) | 3 | $160 |
| Ferring Pharmaceuticals Inc. | 9 | $135 |
| Linkbio Corp | 1 | $119 |
| Linvatec Corporation | 4 | $101 |
| Steris Instrument Management Services, Inc. | 1 | $101 |
| Medacta USA, Inc. | 3 | $100 |
| Innovation Technologies Inc | 1 | $88 |
| Paragon 28, Inc. | 1 | $83 |
| Restor3d, Inc. | 1 | $73 |
| Globus Medical | 2 | $71 |
| Pacira Pharmaceuticals Incorporated | 2 | $66 |
| Medtronic | 3 | $58 |
| Organogenesis Inc. | 2 | $53 |
| Zimmer Biomet | 2 | $44 |
| Pacira Therapeutics, Inc. | 2 | $40 |
| Trice Medical, Inc. | 1 | $35 |
| Medical Device Business Services, Inc. | 1 | $32 |
| Heron Therapeutics, Inc. | 1 | $28 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $27 |
| AbbVie(2 entities) | 2 | $27 |
| DJO, LLC | 1 | $26 |
| Anika Therapeutics, Inc. | 1 | $25 |
| Acera Surgical, Inc. | 1 | $24 |
| Nalu Medical, Inc. | 1 | $24 |
| Alpha Orthopedic Systems | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| KCI USA, Inc. | 1 | $18 |
| AstraZeneca | 1 | $16 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II XR$40,784
- JII Unicondylar Knee System$20,615
- Journey II BCS$16,752
- Navio Surgical System$14,785
- REAL INTELLIGENCE$10,837
- Legion$9,985
- Journey II CR$7,810
- Journey Uni$7,245
- HARMONYAIR SMOKE EVACUATION SYSTEM$6,552
- HARMONYAIR E-SERIES SURGICAL LIGHTING SYSTEM$6,552
- HARMONY IQ 1000 SERIES INTEGRATION SYSTEMS$6,552
- HARMONYAIR A-SERIES SURGICAL LIGHTING SYSTEM$6,552
- CLEANSUITE Operating Room Ceiling System$6,552
- Actera Hip Stem$5,421
- iTotal Hip Replacement System$4,163
- Journey II$3,795
- CORI$2,300
- KNEE3 Software$2,300
- Legion Revision$2,075
- REDAPT Revision Hip System$1,032
How this compares
$83,830 in reported general payments places this provider in the 75th percentile of 27 adult reconstructive orthopaedic surgery providers in Tennessee.
See all adult reconstructive orthopaedic surgery providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 31 | $405 |
| Methocarbamol | 15 | $84 |
| Methylprednisolone | 14 | $83 |
| Tramadol Hcl | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Chattanooga
- Andrew CarloneChattanooga$18K
- Cory CalendineFranklin$2.5M
- William KurtzBrentwood$774K
- Conrad IvieKnoxville$609K
- Brian PerkinsonFranklin$229K
- Andrew ShinarNashville$151K
- William CarpenterNashville$146K
- Christopher HollandGermantown$71K
- Larry JohnsonJackson$55K
- Matthew ChristieNashville$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.